A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under an agreement with the Gates Medic ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published in The Lancet Global Health and supported by the World Health Organization ...

They contribute 6.8% of the world’s total cases according to the World Health Organization (2025). This reality may seem to be a complex reflection of the health crisis present in the Philippines, but ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Tuberculosis (TB) can transmit via the air, and the risk of infection depends on several factors. These can include the duration of exposure, proximity to a person with the infection, and immune ...